Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
10.1007/s00203-017-1459-x Summary Keywords gut microbiota, gastrointestinal diseases, cancer, therapy, dysbiosis Citation Ullah H, Arbab S, Chang C, Bibi S, Muhammad N, Rehman SU, Suleman, Ullah I, Hassan IU, Tian Y and Li K (2025) Gut microbiota therapy in gastrointestinal diseases
Over the study period, 26.36% GLP-1 users discontinued the medication, and around 22.6% stopped using the drug for 6 or more months before continuing treatment
Haisco Pharmaceutical Group Jiangsu Hengrui Medicine Co., Ltd
Published 2021 Nov 3
US$ 28.62
US$ 25.03
US$ 27.73
US$ 20.47
US$ 25.22
US$ 26.71
